Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Steen Bo Wieslander"'
Autor:
Eva Fallentin, Svend Oluf Skouby, Eva Mosfeldt Jeppesen, Anna-Maria Andersson, Heidi Smedegaard, Nini Møller, Hanne Borch-Christensen, Steen Bo Wieslander, Claus Højbjerg Gravholt, Arieh Cohen, Kirsten Holm, Line Cleemann
Publikováno v:
Clinical Endocrinology. 74:756-761
LineCleemann*,KirstenHolm*,EvaFallentin†,SvendOlufSkouby‡,HeidiSmedegaard*,NiniMoller§,HanneBorch-Christensen§,EvaMosfeldtJeppesen–,SteenBoWieslander**,Anna-MariaAndersson††,AriehCohen‡‡andClausHojbjergGravholt§§*DepartmentofPediatr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1169d996c4d46dcfbf6b7c17bd030187
https://doi.org/10.1111/j.1365-2265.2011.03995.x
https://doi.org/10.1111/j.1365-2265.2011.03995.x
Autor:
Sven Oluf Skouby, Anne-Mette Leffers, Kirsten Holm, Claus Højbjerg Gravholt, Per Leth-Espensen, Line Cleemann, Kristian H. Mortensen, Heidi Smedegaard, Erik Morre Pedersen, Steen Bo Wieslander
Publikováno v:
Cleemann, L, Mortensen, K H, Holm, K, Smedegaard, H, Skouby, S O, Wieslander, S B, Leffers, A-M, Leth-Espensen, P, Gravholt, C H & Pedersen, E M 2010, ' Aortic Dimensions in Girls and Young Women with Turner Syndrome: A Magnetic Resonance Imaging Study ', Pediatric Cardiology, vol. 31, no. 4, pp. 497 . https://doi.org/10.1007/s00246-009-9626-8
Udgivelsesdato: 2010-Jan-10 This study aimed to determine the dimensions of the thoracic aorta and the predictors of aortic dimensions in girls and young women with Turner syndrome (TS). A cross-sectional study was performed at a secondary care cente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f062e5bb40de357fd3def1b0a057ed26
https://pubmed.ncbi.nlm.nih.gov/20063160
https://pubmed.ncbi.nlm.nih.gov/20063160
Autor:
Nis I. Nissen, Jørgen K. Larsen, Børge Thing Mortensen, N. R. Hartmann, Tom Kristensen, Ib Jarle Christensen, Steen Bo Wieslander
Publikováno v:
Cell Proliferation. 19:351-364
Cultures of the promyelocytic cell line HL 60 were synchronized with thymidine. A concentration of 0.05 mM thymidine and an exposure time of 24 hr was found optimal for blocking about 90% of the cells in S phase. Following release from the thymidine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29627b305402e5dcc5f1d72a42a4c3df
https://doi.org/10.1111/j.1365-2184.1986.tb00686.x
https://doi.org/10.1111/j.1365-2184.1986.tb00686.x
Publikováno v:
European journal of haematology. 39(1)
10 patients with CLL and 2 with CML were treated with gradually increasing doses of 1 alpha(OH)D3, up to 4 micrograms daily during 6 wk. 3 patients with preleukemia and 1 with myelofibrosis were treated with 2 micrograms daily of 1 alpha(OH)D3 for a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1ba6016dcfdad8d04e5ae2321996e1e
https://pubmed.ncbi.nlm.nih.gov/3477470
https://pubmed.ncbi.nlm.nih.gov/3477470